- Home
- CRBG vs PODD Comparison
CRBG vs PODD Comparison
Compare CRBG & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRBG | PODD |
|---|---|---|
| Founded | 1957 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 17.0B |
| IPO Year | 2022 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CRBG | PODD |
|---|---|---|
| Price | $26.43 | $192.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 20 |
| Target Price | $35.46 | ★ $347.55 |
| AVG Volume (30 Days) | ★ 4.9M | 775.9K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.48 |
| Revenue | ★ $18,481,000,000.00 | $2,708,100,000.00 |
| Revenue This Year | $16.24 | $24.59 |
| Revenue Next Year | $5.65 | $19.18 |
| P/E Ratio | ★ N/A | $57.74 |
| Revenue Growth | N/A | ★ 30.73 |
| 52 Week Low | $22.19 | $194.61 |
| 52 Week High | $36.57 | $354.88 |
Technical Indicators
Market Signals| Indicator | CRBG | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 56.04 | 26.34 |
| Support Level | $22.26 | N/A |
| Resistance Level | $32.44 | $299.75 |
| Average True Range (ATR) | 0.90 | 5.97 |
| MACD | 0.39 | 0.70 |
| Stochastic Oscillator | 67.00 | 3.18 |
Price Performance
Historical ComparisonAbout CRBG Corebridge Financial Inc.
Corebridge Financial Inc provides retirement solutions and insurance products in the United States. It offers a broad set of products and services through five segments Individual Retirement, Group Retirement, Life Insurance, Institutional Markets businesses, Corporate and Other. The majority of its revenue derives from the Individual Retirement segment.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.